Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.
Description
Nanome serves as an interactive platform designed for collaborative molecular visualization and the exploration of drug discovery. Users can upload protein and small-molecule structures to examine together in a three-dimensional format, accessible through a web browser or various XR headsets such as the Meta Quest 3 and 3S, Apple Vision Pro, and Samsung Galaxy XR. In a shared session, all participants, including a chemist using a headset and a peer working from a laptop, can simultaneously focus on the same molecular feature, no matter their physical locations. The platform incorporates MARA, an AI copilot that efficiently performs docking, co-folding, electrostatics calculations, and ADMET predictions based on straightforward, natural language inputs, utilizing over 300 integrated scientific tools to provide 3D models for further examination. Additionally, Nanome supports a variety of file formats including PDB, mmCIF, SDF, MOL2, PyMOL, and Maestro, while also offering connectivity to platforms like Schrodinger LiveDesign, OpenEye, Cresset Flare, CDD Vault, KNIME, and Jupyter. For enterprises, deployment options include single-tenant or on-premises setups, enhancing security and control. A free web seat is available, along with a 14-day complete trial that requires no credit card for access. Overall, Nanome is revolutionizing how teams collaborate in the field of molecular science.
API Access
Has API
No
API Access
Has API
No
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
$20.83/month/user (academic)
Free Trial
Yes
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
Yes
iPhone App
No
iPad App
No
Android App
No
Windows
Yes
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
BenevolentAI
Founded
2013
Country
Luxembourg
Website
www.benevolent.com
Vendor Details
Company Name
Nanome
Founded
2015
Country
United States
Website
nanome.ai
Product Features
Product Features
Alternatives
Alternatives
No Alternatives